Phase 3 VIKTORIA-2 Study: Fulvestrant & CDK4/6i /- Gedatolisib as 1L Treatment in Patients With HR /HER2- Advanced Breast Cancer
Phase 3 VIKTORIA-2 Study: Fulvestrant & CDK4/6i /- Gedatolisib as 1L Treatment in Patients With HR /HER2- Advanced Breast Cancer
7 months ago
vumedi.com
Dr McCann on the Potential Clinical Utility of Gedatolisib in Advanced Breast Cancer | OncLive
1:51
Dr McCann on the Potential Clinical Utility of Gedatolisib in Advanced Breast Cancer | OncLive
6 months ago
onclive.com
Celcuity Inc.: Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium
Celcuity Inc.: Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium
Dec 11, 2024
finanznachrichten.de
Celcuity Inc.: Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-2 Clinical Trial of Gedatolisib as a First-Line Treatment for HR /HER2- Advanced Breast Cancer
Celcuity Inc.: Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-2 Clinical Trial of Gedatolisib as a First-Line Treatment for HR /HER2- Advanced Breast Cancer
10 months ago
finanznachrichten.de
Dr Han on the Investigation of Gedatolisib in HR /HER2– Metastatic Breast Cancer | OncLive
Dr Han on the Investigation of Gedatolisib in HR /HER2– Metastatic Breast Cancer | OncLive
Apr 26, 2023
onclive.com
Celcuity Shares Jump After Phase 3 Trial Shows Gedatolisib Boosts Progression-Free Survival in Breast Cancer
Celcuity Shares Jump After Phase 3 Trial Shows Gedatolisib Boosts Progression-Free Survival in Breast Cancer
7 months ago
marketscreener.com
Celcuity Inc. présente des données précliniques sur les effets thérapeutiques du gédatolisib dans des modèles de cancer du sein lors du 2023 San Antonio Breast Cancer Symposium
Celcuity Inc. présente des données précliniques sur les effets thérapeutiques du gédatolisib dans des modèles de cancer du sein lors du 2023 San Antonio Breast Cancer Symposium
Dec 6, 2023
zonebourse.com
Celcuity dépose une demande de mise sur le marché pour le Gedatolisib dans le traitement du cancer du sein
4 months ago
zonebourse.com
Celcuity Inc. Reports Clinical Data from Two Early Phase Studies of Gedatolisib
10 months ago
marketscreener.com
0:12
Celcuity FDA Acceptance: Gedatolisib in HR+/HER2- Advanced Breast Cancer - MCQs
83 views1 week ago
YouTubeMCQ Pedia
10:10
VIKTORIA-1 Results | Pharmacy Times
5 months ago
pharmacytimes.com
1:09
New PI3K Inhibitor Shows Promise for HER2+ Breast Cancer
26 views4 months ago
YouTubeOncology Perspectives
SABCS 2023 Insights: "VIKTORIA-1 Study of Gedatolisib Fulvestrant /- Palbociclib in Patients With HR / HER2- aBC Previously Treated With CDK4/6i Non-Steroidal Aromatase Inhibitor"
Dec 14, 2023
vumedi.com
0:09
Gedatolisib New Drug Application Submission for Advanced Breast Cancer
230 views2 months ago
YouTubeMCQ Pedia
6:20
CELC Strengthens on Breakthrough Cancer Trial — FDA Approval Next?
22 views7 months ago
YouTubeEquity4keeps
4:45
Synthesis of Gedatolisib
71 viewsMar 12, 2025
YouTubeChemSynth
0:41
Is CELC's Breast Cancer Drug About to Get FDA Approval? #Shorts
4 views3 weeks ago
YouTube100xTrader
4:32
Trending in Oncology: ENHERTU China 2L gastric approval and more
2 views3 months ago
YouTubeLucidQuest
46:53
Celcuity Q1 2026 Earnings Call |Net Loss Of $19.5M As Gedatolisib Phase 3 Clinical Trials Accelerate
1 week ago
YouTubeInvesting 101
0:06
#geometrydash #gd #gdupdate #adlib
37.6K views2 months ago
YouTubenotcoolcomic
9:32
ESMO25 Breast Cancer Highlights: evERA and SERENA6 | Dana-Farber Cancer Institute
332 views6 months ago
YouTubeDana-Farber Cancer Institute
5:26
CELC Breast Cancer Drug Trial: My Take on the 8-K
8 views2 weeks ago
YouTubeCorporate Decoder
2:39
Phase III trial of divarasib versus adagrasib or sotorasib in KRAS G12C-m NSCLC
486 viewsSep 26, 2024
YouTubeVJOncology
18:04
Dr. Erika Hamilton | ER+ Metastatic Breast Cancer
111 views2 months ago
YouTubeOncoAlert 360
23:34
Metastatic HR+ Breast Cancer SABCS 2025 Highlights: Dr. Hope Rugo
6K views4 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discu…
4:38
How does sitagliptin work? DPP-4 inhibitors and GLP-1 mimetics
223.5K viewsDec 6, 2016
YouTubeZero To Finals
1:07:55
PI3K/ AKT/mTOR Pathway Inhibitors in the Treatment of HR+/HER2- Metastatic Breast Cancer
3.9K views7 months ago
YouTubeCancerNet Events
1:05
‏#duet with @Gedi_B #ተዋሕዶ #ለዘለአለም_ፀንታ_ትኖራለች #💚💚💛💛❤️❤️
28.3K viewsNov 19, 2022
TikToklethabeshawe
6:57
How does Dapagliflozin work? Understanding SGLT2 inhibitors.
218.8K viewsJan 31, 2019
YouTubeZero To Finals
2:31
ESMO 2025 Top 10 Must See Breast Cancer Abstracts
603 views7 months ago
YouTubeOncologyTube
See more
Static thumbnail place holder